Androgen receptor expression in triple negative breast cancer: an Algerian population study
Triple-negative breast cancer (TNBC) is a molecular subtype of breast cancer characterized by the absence of estrogen and progesterone receptors and the lack of HER2 overexpression. TNBC is highly heterogeneous, complicating the identification of new therapeutic targets. However, the expression of t...
Saved in:
Main Authors: | Amel Hedjem, Amal Kouchkar, Amel Ladjeroud, Nacera Zerrouki, Fatima Benaissa, Nasir A. Ibrahim, Mohammed Saad Aleissa, Nosiba S. Basher, Assia Derguini, Takfarinas Idres, Karim Houali |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Libyan Journal of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19932820.2025.2535778 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER
by: A. D. Zikiryakhodjhaev, et al.
Published: (2021-03-01) -
Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
by: Hamid Rezvani, et al.
Published: (2025-07-01) -
CLINICAL CHARACTERISTICS OF BREAST CANCER WITH STEROID RECEPTORS EXPRESSION AND HER2 AMPLIFICATION
by: F. V. Moiseenko, et al.
Published: (2017-02-01) -
Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?
by: O. O. Gordeeva, et al.
Published: (2019-04-01) -
Effect of Androgens on Human Fascia
by: Caterina Fede, et al.
Published: (2025-06-01)